HALO logo
halo search icon
Context Therapeutics, Inc.

US$2.23

Price Change Indicator
0.06 (2.76%)
Context Therapeutics, Inc.
CNTX · NAS

Context Therapeutics, Inc.

Start Trading CNTX for Free

US$2.23

Price Arrow0.06 (2.76%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO MomentumHammer BullishHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Context Therapeutics, Inc. Overview

CNTX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CNTX

icon

Website

Context Therapeutics, Inc.

icon

Telephone

1.267.225.7416

icon

Address

Suite 3915, Unit 15, 2001 Market Street, Philadelphia, PA 19103

Description

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. The firm's robust clinical program for candidate onapristone extended release (ONA-XR) comprises three Phase 2 clinical trials and one Phase 1b/2 clinical trial in hormone-driven breast, ovarian and endometrial cancer, as well as two Phase 0 biomarker pharmacodynamic trials in breast cancer. Its ONA-XR is a novel, first-in-class small molecule under development as a complete antagonist of the progesterone receptor, a key unchecked mechanism in hormone-driven women?s cancers. The company was founded by Martin Lehr and Felix Kim in April 2015 and is headquartered in Philadelphia, PA.

CNTX Price Chart

Key Stats

Market Cap

US$199.38M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.49 - 3.62

Trade Value (12mth)

US$333,055.00

1 week

0.46%

1 month

-8.44%

YTD

40%

1 year

214.04%

All time high

10.87

Key Fundamentals

EPS 3 yr Growth

-59.20%

EBITDA Margin

0.00%

Operating Cashflow

-$26m

Free Cash Flow Return

-33.90%

ROIC

-46.40%

Interest Coverage

0.00

Quick Ratio

8.50

Other Data

Shares Outstanding (Fully Diluted)

95m

HALO Sector

Healthcare

Next Company Report Date

24-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CNTX Announcements

Latest Announcements

DateAnnouncements
18 May 26
07 May 26
07 May 26
07 May 26
02 May 26

CNTX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.5-0.46-0.38locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.5-0.46-0.38locklocklock
Growth
 %locklocklocklock-61.569.517locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Context Therapeutics, Inc. (CNTX:NAS)?
Halo FAQ
The current share price of Context Therapeutics, Inc. (CNTX:NAS) is USD$2.23.
What is the 52-week high share price for Context Therapeutics, Inc. (CNTX:NAS)?
Halo FAQ
The 52-week high share price for Context Therapeutics, Inc. (CNTX:NAS) is USD$3.62.
What is the 52-week low share price for Context Therapeutics, Inc. (CNTX:NAS)?
Halo FAQ
The 52-week low share price for Context Therapeutics, Inc. (CNTX:NAS) is USD$0.49.
What is the dividend yield for Context Therapeutics, Inc. (CNTX:NAS)?
Halo FAQ
Context Therapeutics, Inc. (CNTX:NAS) does not pay a dividend.
What was Context Therapeutics, Inc. (CNTX:NAS) last dividend payment?
Halo FAQ
Context Therapeutics, Inc. (CNTX:NAS) does not pay a dividend.
What is the franking level for Context Therapeutics, Inc. (CNTX:NAS)?
Halo FAQ
Context Therapeutics, Inc. (CNTX:NAS) has a franking level of 0.00%.
In which sector is Context Therapeutics, Inc. (CNTX:NAS) classified?
Halo FAQ
Context Therapeutics, Inc. (CNTX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial